Shares of Maximus, Inc. (NYSE:MMS) have been given a consensus rating of “Hold” by the eleven analysts that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation and nine have given a hold recommendation to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $61.00.

MMS has been the topic of several recent research reports. Zacks Investment Research lowered Maximus from a “buy” rating to a “hold” rating in a report on Tuesday. Robert W. Baird reissued a “hold” rating and set a $64.00 price objective on shares of Maximus in a report on Friday, September 1st. Canaccord Genuity lowered Maximus from a “buy” rating to a “hold” rating and set a $62.00 price objective on the stock. in a report on Tuesday, July 4th. Maxim Group set a $66.00 price objective on Maximus and gave the stock a “hold” rating in a report on Thursday, August 3rd. Finally, BidaskClub lowered Maximus from a “hold” rating to a “sell” rating in a report on Monday, July 24th.

In related news, Director Paul R. Lederer sold 2,200 shares of the firm’s stock in a transaction that occurred on Monday, August 14th. The stock was sold at an average price of $60.87, for a total transaction of $133,914.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel David Francis sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, July 14th. The stock was sold at an average price of $60.46, for a total value of $60,460.00. Following the transaction, the general counsel now owns 15,715 shares of the company’s stock, valued at approximately $950,128.90. The disclosure for this sale can be found here. Insiders have sold a total of 152,403 shares of company stock worth $9,414,501 in the last three months. 3.10% of the stock is owned by insiders.

Several institutional investors have recently bought and sold shares of MMS. First Trust Advisors LP lifted its position in shares of Maximus by 12.5% during the 1st quarter. First Trust Advisors LP now owns 25,806 shares of the health services provider’s stock worth $1,605,000 after buying an additional 2,865 shares during the period. Karp Capital Management Corp bought a new position in shares of Maximus during the 1st quarter worth approximately $1,078,000. Stifel Financial Corp lifted its position in shares of Maximus by 3.6% during the 1st quarter. Stifel Financial Corp now owns 8,731 shares of the health services provider’s stock worth $545,000 after buying an additional 302 shares during the period. Clinton Group Inc. bought a new position in shares of Maximus during the 1st quarter worth approximately $311,000. Finally, Arizona State Retirement System lifted its position in shares of Maximus by 7.9% during the 1st quarter. Arizona State Retirement System now owns 27,000 shares of the health services provider’s stock worth $1,679,000 after buying an additional 1,969 shares during the period. Institutional investors and hedge funds own 97.23% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Maximus, Inc. (MMS) Receives $63.00 Average PT from Analysts” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at https://www.thecerbatgem.com/2017/10/11/maximus-inc-mms-receives-63-00-average-pt-from-analysts.html.

Maximus (NYSE:MMS) traded down 0.61% during trading on Friday, hitting $65.37. The stock had a trading volume of 224,164 shares. The firm has a market cap of $4.24 billion, a PE ratio of 20.95 and a beta of 1.36. Maximus has a 52 week low of $43.69 and a 52 week high of $66.38. The company’s 50-day moving average is $62.76 and its 200 day moving average is $61.89.

Maximus (NYSE:MMS) last released its earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.03. The firm had revenue of $600.40 million for the quarter, compared to analyst estimates of $614.12 million. Maximus had a return on equity of 25.08% and a net margin of 8.43%. The company’s revenue was down 2.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.79 EPS. Equities analysts expect that Maximus will post $3.13 EPS for the current fiscal year.

Maximus Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Analyst Recommendations for Maximus (NYSE:MMS)

Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.